Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Sustainable finance in Spain 2024
The OFISO 2025 Annual Report on Sustainable Financing in Spain in 2024 confirms a growth of 8%, to channel 65,705…
Assessing and acting on nature-related issues: Insights from business case studies in the built environment system
The European Horizon SUSTAIN project – Strengthening Understanding and Strategies of Business to Assess and Integrate Nature – which is…
2023
Educational session on draft ESRS 1 General requirements
Sesión educacional conducida por Chiara Del Prete, presidenta del TEG de RS del EFRAG, sobre los requisitos generales recogidos de las…